Thromboembolic events in deceased patients with proven SARS-CoV-2 infection: Frequency, characteristics and risk factors

[1]  E. Lundevaller,et al.  Risks of deep vein thrombosis, pulmonary embolism, and bleeding after covid-19: nationwide self-controlled cases series and matched cohort study , 2022, BMJ.

[2]  H. Ullum,et al.  Risk of hospitalisation associated with infection with SARS-CoV-2 omicron variant versus delta variant in Denmark: an observational cohort study , 2022, The Lancet Infectious Diseases.

[3]  Lisa M. Domke,et al.  First report from the German COVID-19 autopsy registry , 2022, The Lancet Regional Health - Europe.

[4]  Zhaoping Li,et al.  The Impact of Obesity on SARS-CoV-2 Pandemic Mortality Risk , 2021, Nutrients.

[5]  F. Potus,et al.  Venous thromboembolism in COVID-19 compared to non-COVID-19 cohorts: A systematic review with meta-analysis , 2021, Vascular Pharmacology.

[6]  H. Schünemann,et al.  American Society of Hematology 2021 guidelines on the use of anticoagulation for thromboprophylaxis in patients with COVID-19 , 2021, Blood Advances.

[7]  G. Lip,et al.  Clinical characteristics and risk factors for symptomatic venous thromboembolism in hospitalized COVID‐19 patients: A multicenter retrospective study , 2021, Journal of Thrombosis and Haemostasis.

[8]  T. Welte,et al.  Recommendations for treatment of critically ill patients with COVID-19 , 2020, Der Anaesthesist.

[9]  S. Goldhaber,et al.  Registry of Arterial and Venous Thromboembolic Complications in Patients With COVID-19 , 2020, Journal of the American College of Cardiology.

[10]  S. Nopp,et al.  Risk of venous thromboembolism in patients with COVID‐19: A systematic review and meta‐analysis , 2020, Research and Practice in Thrombosis and Haemostasis.

[11]  J. Connors,et al.  The coagulopathy, endotheliopathy, and vasculitis of COVID-19 , 2020, Inflammation Research.

[12]  F. Mussa,et al.  Acute Arterial Thromboembolism in Patients with COVID-19 in the New York City Area , 2020, Annals of Vascular Surgery.

[13]  T. Welte,et al.  Empfehlungen zur intensivmedizinischen Therapie von Patienten mit COVID-19 – 3. Version , 2020, Der Anaesthesist.

[14]  Gheyath K Nasrallah,et al.  D-Dimer Concentrations and COVID-19 Severity: A Systematic Review and Meta-Analysis , 2020, Frontiers in Public Health.

[15]  M. Dimopoulos,et al.  Organ-specific manifestations of COVID-19 infection , 2020, Clinical and Experimental Medicine.

[16]  J. Oldenburg,et al.  Coagulopathy in COVID-19 and Its Implication for Safe and Efficacious Thromboprophylaxis , 2020, Hämostaseologie.

[17]  M. Aepfelbacher,et al.  Dying with SARS-CoV-2 infection—an autopsy study of the first consecutive 80 cases in Hamburg, Germany , 2020, International Journal of Legal Medicine.

[18]  O. Müller,et al.  Venous thromboembolism in patients with COVID-19 (SARS-CoV-2 infection) - a position paper of the German Society of Angiology (DGA). , 2020, VASA. Zeitschrift fur Gefasskrankheiten.

[19]  Axel Haverich,et al.  Pulmonary Vascular Endothelialitis, Thrombosis, and Angiogenesis in Covid-19. , 2020, The New England journal of medicine.

[20]  M. Trauner,et al.  Pulmonary Arterial Thrombosis in COVID-19 With Fatal Outcome: Results From a Prospective, Single-Center, Clinicopathologic Case Series , 2020, Annals of Internal Medicine.

[21]  M. Aepfelbacher,et al.  Autopsy Findings and Venous Thromboembolism in Patients With COVID-19 , 2020, Annals of Internal Medicine.

[22]  K. Mertz,et al.  Postmortem examination of COVID‐19 patients reveals diffuse alveolar damage with severe capillary congestion and variegated findings in lungs and other organs suggesting vascular dysfunction , 2020, Histopathology.

[23]  J. Connors,et al.  COVID-19 and its implications for thrombosis and anticoagulation , 2020, Blood.

[24]  Nils Kucher,et al.  Venous and arterial thromboembolic complications in COVID-19 patients admitted to an academic hospital in Milan, Italy , 2020, Thrombosis Research.

[25]  L. Beenen,et al.  Incidence of venous thromboembolism in hospitalized patients with COVID‐19 , 2020, Journal of Thrombosis and Haemostasis.

[26]  Dengju Li,et al.  Anticoagulant treatment is associated with decreased mortality in severe coronavirus disease 2019 patients with coagulopathy , 2020, Journal of Thrombosis and Haemostasis.

[27]  C. Grohé.  Pneumonie , 2020, DMW - Deutsche Medizinische Wochenschrift.

[28]  Dengju Li,et al.  Abnormal coagulation parameters are associated with poor prognosis in patients with novel coronavirus pneumonia , 2020, Journal of Thrombosis and Haemostasis.

[29]  G. Gao,et al.  A Novel Coronavirus from Patients with Pneumonia in China, 2019 , 2020, The New England journal of medicine.

[30]  J. Tran van Nhieu,et al.  DNA degrades during storage in formalin-fixed and paraffin-embedded tissue blocks , 2017, Virchows Archiv.

[31]  G. Vilahur,et al.  New insights into the role of adipose tissue in thrombosis , 2017, Cardiovascular research.

[32]  M. Franchini,et al.  Classic thrombophilic gene variants , 2015, Thrombosis and Haemostasis.

[33]  F. Violi,et al.  Pneumonia, thrombosis and vascular disease , 2014, Journal of thrombosis and haemostasis : JTH.

[34]  Giancarlo Agnelli,et al.  Oral apixaban for the treatment of acute venous thromboembolism. , 2013, The New England journal of medicine.

[35]  P. Woo,et al.  Phylogenetic and recombination analysis of coronavirus HKU1, a novel coronavirus from patients with pneumonia , 2005, Archives of Virology.

[36]  H. Doyle.  Work of breathing during intermittent mandatory ventilation. , 1986, Critical care medicine.